SAN DIEGO, March 17, 2026 (GLOBE NEWSWIRE)-- Boundless Bio (Nasdaq: BOLD), a clinical-stage oncology company interrogating extrachromosomal DNA (ecDNA) biology to deliver transformative therapies to ...
Background: Although brain and heart conditions share overlapping risk factors and commonly co-occur, current cardiac and neurologic clinical guidelines are typically produced within specialty silos.
BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a biopharmaceutical company focused on developing medicines for genetic conditions, announced today that long-term efficacy and ...
Poster hang up: 9:00 a.m. - 10:00 a.m. Poster presentations: 10 a.m. - 12 p.m. Poster judging: 10 a.m. - 11 a.m. Awards presentation: 12:30 p.m. - 1:00 p.m. The ...
Oxford, UK - March 17, 2026. Enara Bio, a pioneer in Dark Antigen® discovery and bispecific T cell engager innovation, today announced new data to be presented at the American Association for Cancer ...
Amy Danise is the former managing editor for the insurance section at Forbes Advisor, which encompasses auto, home, renters, life, pet, travel, health and small business insurance. She is a highly ...
Zacks Small Cap Research on MSN
ICU: Poster presentations at AKI & CRRT 2026 highlight SAVE registry data and SCD MOA
By David Bautz, PhD NASDAQ: ICU READ THE FULL ICU RESEARCH REPORT Business Update Presentations Highlight SAVE Registry Data ...
Bio-Rad Laboratories, Inc. engages in the development, manufacturing, and marketing of a portfolio of instruments, systems, reagents, and consumables. It operates through the following segments: Life ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results